Evidence mapPaperPMID 33303102Full record

GuidelineJACC. Cardiovascular imaging2020

Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19: An Expert Consensus Statement.

Dermot Phelan, Jonathan H Kim, Michael D Elliott, Meagan M Wasfy, Paul Cremer, Amer M Johri, Michael S Emery, Partho P Sengupta, Sanjay Sharma, Matthew W Martinez and 1 more

Open access · greenAbstract readPractice GuidelineReviewConsensus Statement
In one paragraph

Guideline in JACC. Cardiovascular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 2 pooled it
16.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 2 syntheses or guidelines pooled it, 128 citations in OpenAlex.

  1. Prevalence of abnormal cardiovascular magnetic resonance findings in recovered patients from COVID-19: a systematic review and meta-analysis.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2021
    Pooled it
  2. Pooled it
  3. Review
  4. "Bridging the clinical, molecular and genetic perspectives on myocarditis in post-COVID-19 era".International journal of cardiology. Cardiovascular risk and prevention · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 4 countries.

Dermot PhelanSanger Heart and Vascular Institute, Atrium Health, Charlotte, North Carolina, USA. Electronic address: dermot.phelan@atriumhealth.org.
Jonathan H KimEmory Clinical Cardiovascular Research Institute, Emory School of Medicine, Atlanta, Georgia, USA.
Michael D ElliottSanger Heart and Vascular Institute, Atrium Health, Charlotte, North Carolina, USA.
Meagan M WasfyDivision of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Paul CremerHeart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Amer M JohriDepartment of Medicine, Queens University, Kingston, Ontario, Canada.
Michael S EmeryHeart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Partho P SenguptaHeart and Vascular Institute, West Virginia University, Morgantown, West Virginia, USA.
Sanjay SharmaCardiology Clinical Academic Group, St. George's University Hospital, London, United Kingdom.
Matthew W MartinezDepartment of Cardiovascular Medicine, Morristown Medical Center, Atlantic Health, Morristown, New Jersey, USA.
Andre La GercheClinical Research Domain, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Cleveland Clinic · USAtrium Medical Cente · USBaker Heart and Diabetes Institute · AUEmory Healthcare · USMassachusetts General Hospital · USMorristown Medical Center · USQueen's University · CASt George's Hospital · GBWest Virginia University · US

Funding

West Virginia Clinical and Translational Science Institute: A Statewide Organization Building Research Excellence and Engaging Communities to Improve HealthU54GM104942 · WEST VIRGINIA UNIVERSITY · 2025 to 2025
$4.0M
NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

As our understanding of the complications of coronavirus disease-2019 (COVID-19) evolve, subclinical cardiac pathology such as myocarditis, pericarditis, and right ventricular dysfunction in the absence of significant clinical symptoms represents a concern. The potential implications of these findings in athletes are significant given the concern that exercise, during the acute phase of viral myocarditis, may exacerbate myocardial injury and precipitate malignant ventricular arrhythmias. Such concerns have led to the development and publication of expert consensus documents aimed at providing guidance for the evaluation of athletes after contracting COVID-19 in order to permit safe return to play. Cardiac imaging is at the center of these evaluations. This review seeks to evaluate the current evidence regarding COVID-19-associated cardiovascular disease and how multimodality imaging may be useful in the screening and clinical evaluation of athletes with suspected cardiovascular complications of infection. Guidance is provided with diagnostic "red flags" that raise the suspicion of pathology. Specific emphasis is placed on the unique challenges posed in distinguishing athletic cardiac remodeling from subclinical cardiac disease. The strengths and limitations of different imaging modalities are discussed and an approach to return to play decision making for athletes post-COVID-19, as informed by multimodality imaging, is provided.

Indexed as

AthletesCompetitive BehaviorReturn to SportCardiorespiratory FitnessComputed Tomography AngiographyConsensusCoronary AngiographyCOVID-19EchocardiographyHeart DiseasesHumansMagnetic Resonance ImagingMultimodal ImagingPredictive Value of TestsPrognosisRisk AssessmentathleteCOVID-19multimodality imagingmyocardial injurymyocarditisreturn to play

Identifiers

PMID33303102
PMCPMC7598679
OpenAlexW3096482078

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.